Long-term response to daratumumab in a patient with advanced immunoglobulin light-chain (AL) amyloidosis with organ damage.

MLA

Canichella, Martina, et al. “Long-Term Response to Daratumumab in a Patient with Advanced Immunoglobulin Light-Chain (AL) Amyloidosis with Organ Damage.” Annals of Hematology, vol. 98, no. 4, Apr. 2019, pp. 1047–48. EBSCOhost, https://doi.org/10.1007/s00277-018-3566-4.

APA

Canichella, M., Serrao, A., Annechini, G., D, E. G. M., De Luca, M. L., Pulsoni, A., & D’Elia, G. M. (2019). Long-term response to daratumumab in a patient with advanced immunoglobulin light-chain (AL) amyloidosis with organ damage. Annals of Hematology, 98(4), 1047–1048. https://doi.org/10.1007/s00277-018-3566-4

Chicago

Canichella, Martina, Alessandra Serrao, Giorgia Annechini, Elia, Gianna Maria D, Maria Lucia De Luca, Alessandro Pulsoni, and Gianna Maria D’Elia. 2019. “Long-Term Response to Daratumumab in a Patient with Advanced Immunoglobulin Light-Chain (AL) Amyloidosis with Organ Damage.” Annals of Hematology 98 (4): 1047–48. doi:10.1007/s00277-018-3566-4.